Skip to main content

ERRATUM article

Front. Oncol., 05 January 2024
Sec. Cancer Immunity and Immunotherapy
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1356381

Erratum: Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications

This article is an erratum on:

  1. Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications

    1. Read original article
Frontiers Production Office* Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications

By Rodriguez-Lara V, Giovanny S-C, Avila-Costa MR, Whaley JJJ-V, Rodriguez-Cid JR, Ordoñez-Librado JL, Rodriguez-Maldonado E and Heredia-Jara NA (2023) Front. Oncol. 13:1210297. doi: 10.3389/fonc.2023.1210297

Due to a production error, an author name was incorrectly spelled as “Soca-Chafre Giovanny”. The correct spelling is “Giovanny Soca-Chafre”.

The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: NSCLC, PD-1/PD-L1 pathway, immunotherapy, estrogen, androgen

Citation: Frontiers Production Office (2024) Erratum: Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications. Front. Oncol. 13:1356381. doi: 10.3389/fonc.2023.1356381

Received: 15 December 2023; Accepted: 15 December 2023;
Published: 05 January 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.